Sending Office: Honorable Raja Krishnamoorthi
Endorsing Organizations: Parents Against Vaping E-cigarettes (PAVE), National Association of Secondary School Principals, Respiratory Health Association
Current Cosponsors: Raja Krishnamoorthi, TJ Cox, Susan Wild, Steve Cohen, Mark DeSaulnier, Alcee Hastings, Eleanor Holmes Norton
Please join me in cosponsoring H.R. 4624, the Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act, which is the next step in the right direction as we work to end the public health crisis that is the youth vaping epidemic.
Flavorful e-cigarettes attract kids, but extreme nicotine levels is what keeps them addicted. In the last two years, the United States has witnessed a 135% increase in youth e-cigarette use. This dramatic spike in youth vaping was ignited by new technology
which allows manufacturers to increase the amount of addictive nicotine in e-cigarettes while simultaneously masking the harsh taste with attractive flavors. For reference, most e-cigarettes prior to 2016 contained between 10 and 20 milligrams per milliliter
(mg/ml) of nicotine. E-cigarettes today, commonly referred to “fourth generation e-cigarette devices” by the CDC, are significantly more addictive, containing up to 59 mg/ml.
In the EU, UK, and Israel, e-cigarettes are capped at 20 mg/ml, and between 2017 and 2019, these countries did not see the similar skyrocket of e-cigarette use among youth as the United States. As a reminder, e-cigarette use among high schoolers and middle
schoolers is up 135% between 2017 and 2019. In the UK, less than 5% of youth are vaping.
The END ENDS Act will cap nicotine levels in e-cigarettes to 20 mg/ml, or a lower amount deemed by the FDA Secretary to be “minimally addictive or non-addictive”. In addition, this bill will encourage the FDA to successfully replicate international efforts
to prevent youth from using e-cigarettes, and to examine other ways that these fourth generation e-cigarettes can be redesigned to be less appealing to youth. This bill is essential in laying the marker to regulate products which, until this point, have gone
basically untouched since coming to the market.
If you would like to become a cosponsor or have questions, please contact Grace Carmichael, email@example.com or 5-7732.
Member of Congress
e-Dear Colleague version 2.0